tradingkey.logo
tradingkey.logo
Pesquisar

Co-Diagnostics Inc

CODX
Adicionar à lista de desejos
2.990USD
-0.090-2.92%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
10.77MValor de mercado
PerdaP/L TTM

Mais detalhes de Co-Diagnostics Inc Empresa

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Informações de Co-Diagnostics Inc

Código da empresaCODX
Nome da EmpresaCo-Diagnostics Inc
Data de listagemJul 12, 2017
CEOEgan (Dwight H)
Número de funcionários132
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 12
Endereço2401 S. Foothill Dr. Suite D
CidadeSALT LAKE CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84109
Telefone18014381036
Sitehttps://codiagnostics.com/
Código da empresaCODX
Data de listagemJul 12, 2017
CEOEgan (Dwight H)

Executivos da empresa Co-Diagnostics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Co-Diagnostics Inc?

Os cinco principais acionistas de Co-Diagnostics Inc são: Mr. Richard S. Serbin

Quantas instituições possuem ações da Co-Diagnostics Inc (CODX)?

Em 2026Q1, 75 instituições possuíam ações da Co-Diagnostics Inc, com valor de mercado aproximado de 248.15K, representando 6.89% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -158736.00.